» Articles » PMID: 29600913

Natural History of Cavernous Sinus Meningiomas

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2018 Mar 31
PMID 29600913
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Meningiomas confined to the cavernous sinus (MCSs) are benign tumors. Due to the high risk of severe complications, the intracavernous surgical procedure was abandoned in favor of radiotherapy. However, the choice of treatment remains complicated due to the fact that the natural history of this lesion has not yet been described.

Methods: The authors studied the natural history of this lesion using a prospective series of 53 consecutive patients suffering from MCSs. The median follow-up duration was 10.2 years (range 2-25 years), from 1990 to 2016.

Results: Patients ranged in age from 30 to 72 years (mean 53 years). The meningiomas were diagnosed by major symptoms (mainly oculomotor palsy and neuralgia experienced in 28 patients), minor symptoms (headache, intermittent diplopia in 15 patients), or incidental findings (10 patients). Simple symptomatic treatment (short courses of corticosteroids and carbamazepine) allowed patients to become asymptomatic in 19 (67.9%) of 28 cases experiencing major symptoms, and for 12 (80%) of 15 patients with initial minor symptoms (p < 0.0001). All patients with incidental findings remained asymptomatic. Forty four (83%) of 53 MCSs did not show any significant growth and 42 (80%) of 53 patients were not symptomatic at the end of follow-up (p < 0.001). The radiographic progression-free survival rates (± SD) at 5, 10, and 20 years were 90% ± 4.2%, 82% ± 5.7%, and 70% ± 10.2%, respectively. Five patients (9.4%) with no evidence of any effect of the initial medical treatment desired additional conventional radiation therapy.

Conclusions: Because of the capricious, unpredictable, and slow growth of MCSs, together with high growth variability from one patient to the next, the symptomatic medical treatment of these tumors is a highly effective method. This series shows that these lesions are naturally, clinically, and radiologically indolent.

Citing Articles

Cerebrospinal fluid oculorrhea: A rare complication after orbital exenteration for cavernous sinus meningioma with orbital extension and radiation-induced hydrocephalus.

Ichinose T, Sasagawa Y, Yoshiki K, Tamai S, Tanaka S, Nakada M Surg Neurol Int. 2025; 16:9.

PMID: 39926457 PMC: 11799716. DOI: 10.25259/SNI_780_2024.


Recovery of cranial nerve neuropathies after LINAC-based stereotactic radiosurgery for benign cavernous sinus meningioma.

Kaisman-Elbaz T, Blumenfeld P, Wygoda M, Feldman J, Shoshan Y J Neurooncol. 2024; 170(1):119-128.

PMID: 39088156 PMC: 11446963. DOI: 10.1007/s11060-024-04783-3.


Risk of Tumor Progression after Microsurgery for Parasellar Meningioma Invading the Cavernous Sinus.

Nowak A, Maj E, Marchel A, Kunert P Cancers (Basel). 2024; 16(12).

PMID: 38927924 PMC: 11202088. DOI: 10.3390/cancers16122217.


Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section.

Corniola M, Roche P, Bruneau M, Cavallo L, Daniel R, Messerer M Brain Spine. 2022; 2:100864.

PMID: 36248124 PMC: 9560706. DOI: 10.1016/j.bas.2022.100864.


Predictors of improvement in quality of life at 12-month follow-up in patients undergoing anterior endoscopic skull base surgery.

Buchlak Q, Esmaili N, Bennett C, Wang Y, King J, Goldschlager T PLoS One. 2022; 17(7):e0272147.

PMID: 35895728 PMC: 9328523. DOI: 10.1371/journal.pone.0272147.